Skip to content
MarketScale
‹ Back to IndustriesSciences

WATCH: Jeff Bezos’ First Interview After Returning from Space

Amazon.com co-founder Jeff Bezos returned safely from Blue Origin’s first-ever crewed space flight. Tune in below to watch his first televised interview and hear his initial reactions after landing back on earth. “Honestly, I’m not talented enough to describe this in words. I can’t figure it out. It was much more than I expected. It’s…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · BezosBloombergBlue OriginJeff Bezos
Share

Key takeaways

01

Amazon.com co-founder Jeff Bezos returned safely from Blue Origin’s first-ever crewed space flight.

02

Tune in below to watch his first televised interview and hear his initial reactions after landing back on earth.

03

“Honestly, I’m not talented enough to describe this in words.

Amazon.com co-founder Jeff Bezos returned safely from Blue Origin’s first-ever crewed space flight. Tune in below to watch his first televised interview and hear his initial reactions after landing back on earth.

“Honestly, I’m not talented enough to describe this in words. I can’t figure it out. It was much more than I expected. It’s awe inspiring.”

Host: Welcome back to Earth. How do you feel?

Bezos: Oh, my goodness. Wow.

Host: This is your first interview since landing. We all want to know the reality of seeing the Earth from above. Did it live up to the dream beyond?

Bezos: Honestly, I’m not talented enough to describe this in words. I can’t figure it out. It was much more than I expected. It’s awe inspiring. It’s just I don’t know. Do you have words? I don’t have words. It it was truly it was one of the most beautiful sights I’ve ever seen.

Host: So now that you’re here, now that you’ve accomplished this, what’s Blue’s next move? How does this fit into the long term vision with a long term vision?

Bezos: We’re building an orbital vehicle called New Glenn. And this vehicle we just flew, New Shepard is our suborbital tourism vehicle. So we’re going to fly that over and over and over at every time we fly it.

It’s practice for the orbital mission. And it gives people a chance to see what we just saw, which is this fragile, beautiful Earth that you can’t imagine. People can tell you about it.

But until you see with your own eyes, I don’t know, maybe we need to send a prototype or something. Somebody who’d be better at describing it. But I can tell you is that it’s just this thing that you can’t tell.

You can see that it’s just one place. There’s no boundaries, no national lines, nothing. The atmosphere.

We see the Earth’s atmosphere. It’s so big. We live in it.

It seems gigantic. But when you get up there, you see that it’s actually this teensy little thing that we need to protect. So I don’t know.

For me, it was definitely incredible. Yeah, it was amazing. I was surprised at how easy it was to move around in Zero-G.

That was probably the most surprising. Yeah, it felt almost normal. It felt like, you know, it felt like we were somehow evolved to be in Zero-G, it felt so good.

Host: So for the people here on Earth who are wondering why are we investing all this money in space. This time and space, talk to us about how you believe this will actually help benefit us here on Earth.

Bezos: Yeah, well, this is what we’re doing is we’re building infrastructure. This is a road building a road to space. So that future generations can build the future. We live on this beautiful planet. It’s the most beautiful planet in the solar system by far. And we have to keep it safe and protect it. And the way to do that is slowly over decades to move all heavy industry, all polluting industry out into space. That’s what we’re going to do. So we can keep this planet. The gym that it is. But to do that, we need reusable spacecraft. We need low cost spacecraft. To get that, we’ve got to practice. And that’s what this tourism mission is about.

Host: We saw your kids greet you on the ground. I have four kids for the kids watching. What how do you want this to inspire them?

Bezos: Well, you know, kids are they are all if every kid has so much potential inside of them. And I hope that what we’re doing a little bit is, is unlocking that. So for kids everywhere, if the way you unlock potential is with inspiration, I was inspired as a little boy by the Apollo astronauts. And, you know, this is a next phase of commercial space development. And I hope that inspires little kids to.

*Bloomberg contributed to this content

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Video TranscriptExpand ↓

Welcome back to Earth. How do you feel? Oh, my goodness. Wow, I mean, wow, this is your first interview since landing. We all want to know the reality of seeing the Earth from above. Did it live up to the dream beyond? Honestly, I'm not talented enough to describe this in words. I can't figure it out. It was much more than I expected. It's awe inspiring. It's just I don't know. Do you have words? I don't have words. It it was truly it was one of the most beautiful sights I've ever seen. So now that you're here, now that you've accomplished this, what's blues next move? How does this fit into the long term vision with a long term vision? We're building an orbital vehicle called new Glenn. And this vehicle we just flew, new Shepard is our suborbital tourism vehicle. So we're going to fly that over and over and over at every time we fly it. It's practice for the orbital mission. And it gives people a chance to see what we just saw, which is this fragile, beautiful Earth that you can't imagine. People can tell you about it. But until you see with your own eyes, I don't know, maybe we need to send a prototype or something. Somebody who'd be better at describing it. But I can tell you is that it's just this thing that you can't tell. You can see that it's just one place. There's no boundaries, no national lines, nothing. The atmosphere. We see the Earth's atmosphere. It's so big. We live in it. It seems gigantic. But when you get up there, you see that it's actually this teensy little thing that we need to protect. So I don't know. For me, it was definitely incredible. Yeah, it was amazing. I was surprised at how easy it was to move around in 0 G. That was probably the most surprising. Yeah, it felt almost normal. It felt like, you know, it felt like we were somehow evolved to be a 0 g it felt so good. So for the people here on Earth who are wondering why are we investing all this money in space. This time and space, talk to us about how you believe this will actually help benefit us here on Earth. Yeah, well, this is what we're doing is we're building infrastructure. This is a road building a road to space. So that future generations can build the future. We live on this beautiful planet. It's the most beautiful planet in the solar system by far. And we have to keep it safe and protect it. And the way to do that is slowly over decades to move all heavy industry, all polluting industry out into space. That's what we're going to do. So we can keep this planet. The gym that it is. But to do that, we need reusable spacecraft. We need low cost spacecraft. To get that, we've got to practice. And that's what this tourism mission is about. We saw your kids greet you on the ground. I have four kids for the kids watching. What how do you want this to inspire them? Well, you know, kids are they are all if every kid has so much potential inside of them. And I hope that what we're doing a little bit is, is unlocking that. So for kids everywhere, if the way you unlock potential is with inspiration, I was inspired as a little boy by the Apollo astronauts. And, you know, this is a next phase of commercial space development. And I hope that inspires little kids to.

About the author

S
Sciences

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

The pharmaceutical industry is facing a significant challenge as over $300 billion in branded pharmaceutical revenue is set to lose patent protection by 2030. This revenue gap is driving the largest merger and acquisition cycle seen in a decade, with companies seeking external growth through acquisitions. This shift is impacting the entire life sciences supply chain, prompting strategic changes across the industry.

  • 01Over $300 billion in pharmaceutical revenue is at risk due to patent expirations by 2030.
  • 02Big Pharma is engaging in an aggressive cycle of mergers and acquisitions.
  • 03The acquisitions are reshaping the life sciences supply chain.

Jun 29, 2026

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I clinical study of an oral solid dose formulation designed using AI, cleared by the UK's MHRA and conducted at the company's UK facility. The trial—built on machine learning algorithms from partner Intrepid Labs and Quotient's Translational Pharmaceutics platform—aims to validate AI as a direct contributor to formulation design rather than just an upstream analytical tool. Benchling characterizes the broader moment as biotech entering a "builder phase," in which leading organizations embed AI capability at the bench level rather than running isolated pilots.

  • 01Quotient Sciences has dosed healthy volunteers in a Phase I study it describes as the first clinical evaluation of an AI-designed oral formulation, following approval from the UK's MHRA.
  • 02The formulation was developed using advanced machine learning algorithms from Intrepid Labs, integrated with Quotient Sciences' Translational Pharmaceutics platform.
  • 03Benchling identifies a sector-wide shift toward embedding AI capability directly at the bench, moving beyond isolated pilots to structural adoption across biotech R&D.

Jun 17, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences